AmbioPharm, a company involved in peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) services, appointed industry veteran Brian Gregg CEO. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after seven years with the company. Gregg joins AmbioPharm following a 32-year career at Bachem Americas, where he was COO for nearly a decade and was responsible for driving bu...